Taking the Road Less Traveled: Following Molecular Trail Markers.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Targeted therapy largely remains an unmet therapeutic need for low-grade serous ovarian carcinomas. However, recent advances in molecular characterization are beginning to change the landscape. A recent article highlights the association of genetic alterations with clinical outcomes, widening the scope of novel targeted therapies. See related article by Manning-Geist et al., p. 4456.

Keyphrases

high grade
low grade
genome wide
single cell
single molecule
gene expression
dna methylation